DK323486A - Monoklont antistof mod et med human carcinom associeret antigen - Google Patents

Monoklont antistof mod et med human carcinom associeret antigen Download PDF

Info

Publication number
DK323486A
DK323486A DK323486A DK323486A DK323486A DK 323486 A DK323486 A DK 323486A DK 323486 A DK323486 A DK 323486A DK 323486 A DK323486 A DK 323486A DK 323486 A DK323486 A DK 323486A
Authority
DK
Denmark
Prior art keywords
monoclont
carcinom
human
antibody against
antigen associated
Prior art date
Application number
DK323486A
Other languages
English (en)
Other versions
DK323486D0 (da
Inventor
Kenneth H Kortright
David E Hofheinz
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Corp filed Critical Coulter Corp
Publication of DK323486A publication Critical patent/DK323486A/da
Publication of DK323486D0 publication Critical patent/DK323486D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK323486A 1984-11-09 1986-07-07 Monoklont antistof mod et med human carcinom associeret antigen DK323486D0 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67032884A 1984-11-09 1984-11-09
US06/702,059 US4708930A (en) 1984-11-09 1985-02-15 Monoclonal antibody to a human carcinoma tumor associated antigen
PCT/US1985/001511 WO1986002945A1 (en) 1984-11-09 1985-08-08 Monoclonal antibody to a human carcinoma tumor associated antigen

Publications (2)

Publication Number Publication Date
DK323486A true DK323486A (da) 1986-07-07
DK323486D0 DK323486D0 (da) 1986-07-07

Family

ID=27100290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK323486A DK323486D0 (da) 1984-11-09 1986-07-07 Monoklont antistof mod et med human carcinom associeret antigen

Country Status (14)

Country Link
US (1) US4708930A (da)
EP (1) EP0201509B1 (da)
KR (1) KR900003923B1 (da)
CN (1) CN1009055B (da)
AU (1) AU593467B2 (da)
BR (1) BR8507031A (da)
CA (1) CA1243969A (da)
DE (1) DE3574730D1 (da)
DK (1) DK323486D0 (da)
ES (1) ES8705975A1 (da)
HU (1) HUT40692A (da)
IL (1) IL76142A (da)
NO (1) NO862641L (da)
WO (1) WO1986002945A1 (da)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188967A (en) * 1985-05-02 1993-02-23 Institut Pasteur Agents for the in vitro diagnosis of malignant cells originating in the digestive tract
US5635389A (en) * 1985-05-02 1997-06-03 Institut Pasteur Antibodies which recognize and bind human villin
US4916055A (en) * 1985-12-13 1990-04-10 Baylor College Of Medicine Detection of human cancer with a monoclonal antibody specific for antigen gp650
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
EP0232871A3 (en) * 1986-02-07 1989-03-15 Yoshitomi Pharmaceutical Industries, Ltd. Human monoclonal antibody, hybridoma producing the same and its use
US4863851A (en) * 1986-10-20 1989-09-05 The Upjohn Company Monoclonal antibody to prostate secretory protein
DE3713301A1 (de) * 1987-04-18 1988-11-03 Becker Helmut Dipl Wirtsch Ing Verfahren zur durchflussmengenmessung und thermischer durchflussgeber hierfuer
CA1340927C (en) * 1987-10-09 2000-03-14 Peter S. Linsley Method for increasing the sensitivity of assays for target ligand
US5241052A (en) * 1988-03-04 1993-08-31 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US5204450A (en) * 1988-03-04 1993-04-20 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US4914021A (en) * 1988-03-04 1990-04-03 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US5171666A (en) * 1988-04-22 1992-12-15 Eli Lilly And Company Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
US5134075A (en) * 1989-02-17 1992-07-28 Oncogen Limited Partnership Monoclonal antibody to novel antigen associated with human tumors
FR2645877B1 (fr) * 1989-04-12 1991-07-05 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un, ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum au niveau du stade sporozoite et dans les hepatocytes
US5171665A (en) * 1989-04-17 1992-12-15 Oncogen Monoclonal antibody to novel antigen associated with human tumors
IL94872A (en) * 1989-06-30 1995-03-30 Oncogen Monoclonal or chimeric antibodies that react with human carcinoma, recombinant proteins that contain their anti-binding site, pharmaceutical preparations and kits that contain the
US6020145A (en) * 1989-06-30 2000-02-01 Bristol-Myers Squibb Company Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
US5980896A (en) * 1989-06-30 1999-11-09 Bristol-Myers Squibb Company Antibodies reactive with human carcinomas
EP0460607A3 (en) * 1990-06-05 1992-04-01 Bristol-Myers Squibb Company Novel monoclonal antibody to novel antigen associated with human tumors
AU5615594A (en) * 1992-11-13 1994-06-08 Cancer Research Fund Of Contra Costa Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods
CA2149529C (en) * 1992-11-16 2006-05-02 Fernado J. R. Do Couto Peptides and anti-sense peptides with broad neoplastic specificity
US5792852A (en) * 1992-11-16 1998-08-11 Cancer Research Fund Of Contra Costa Polynucleotides encoding modified antibodies with human milk fat globule specificity
US5804187A (en) 1992-11-16 1998-09-08 Cancer Research Fund Of Contra Costa Modified antibodies with human milk fat globule specificity
US6281335B1 (en) 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
CA2154266A1 (en) * 1993-02-05 1994-08-18 John F. Codington Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
US5792456A (en) * 1994-08-04 1998-08-11 Bristol-Myers Squibb Company Mutant BR96 antibodies reactive with human carcinomas
US5728821A (en) * 1994-08-04 1998-03-17 Bristol-Myers Squibb Company Mutant BR96 antibodies reactive with human carcinomas
US6309636B1 (en) * 1995-09-14 2001-10-30 Cancer Research Institute Of Contra Costa Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
US20020192211A1 (en) * 1998-03-17 2002-12-19 Hudziak Robert M. Method of treating tumor cells by inhibiting growth factor receptor function
US20020147143A1 (en) 1998-03-18 2002-10-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030235557A1 (en) 1998-09-30 2003-12-25 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
US6471968B1 (en) 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
WO2002000174A2 (en) 2000-06-28 2002-01-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
ZA200305980B (en) 2001-02-12 2007-01-31 Res Dev Foundation Modified proteins, designer toxins, and methods of making thereof
JP2004535202A (ja) 2001-07-17 2004-11-25 リサーチ　ディベロップメント　ファンデーション アポトーシス促進性蛋白質を含む治療剤
AU2002365279B2 (en) 2001-12-17 2009-08-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
JP2007504244A (ja) * 2003-09-05 2007-03-01 ザ スクリプス リサーチ インスティテュート アテローム硬化症および／または心血管性疾患の処置および予防のためのコレステロールのオゾン化産物
BRPI0414154A (pt) * 2003-09-05 2006-10-31 Scripps Resarch Inst detecção de produtos de ozonização do colesterol
US8470315B2 (en) 2004-04-13 2013-06-25 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
JP2008510829A (ja) * 2004-08-25 2008-04-10 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン デンドリマーに基づく組成物およびそれらの使用法
US20070041934A1 (en) * 2005-08-12 2007-02-22 Regents Of The University Of Michigan Dendrimer based compositions and methods of using the same
RS52804B (en) * 2005-12-08 2013-10-31 Medarex Inc. HUMAN MONOCLONAL ANTIBODIES TO PROTEIN TYROSINE KINASE 7 (PTK7) AND THEIR USE
US7501179B2 (en) 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8840882B2 (en) * 2006-06-23 2014-09-23 Quintessence Biosciences, Inc. Modified ribonucleases
US8298801B2 (en) * 2006-07-17 2012-10-30 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
AU2008275501A1 (en) * 2007-04-19 2009-01-15 The Regents Of The University Of Michigan Dendrimer based compositions and methods of using the same
US7890055B1 (en) * 2007-07-09 2011-02-15 Everlokt Corporation Touch field compound field detector personal ID
WO2009026540A1 (en) * 2007-08-22 2009-02-26 Colorado School Of Mines Lanthanide nanoparticle conjugates and uses thereof
EP2205271B1 (en) * 2007-10-08 2014-05-21 Quintessence Biosciences, Inc. Compositions and methods for ribonuclease-based therapies
US8252834B2 (en) 2008-03-12 2012-08-28 The Regents Of The University Of Michigan Dendrimer conjugates
US8968705B2 (en) 2008-08-22 2015-03-03 Colorado School Of Mines Gold/lanthanide nanoparticle conjugates and uses thereof
US8889635B2 (en) 2008-09-30 2014-11-18 The Regents Of The University Of Michigan Dendrimer conjugates
EP2334695B1 (en) 2008-10-01 2015-12-23 Quintessence Biosciences, Inc. Therapeutic ribonucleases
EP2352490A4 (en) 2008-10-09 2013-11-20 Univ Northeastern SELF-ARRANGING POLYMER MULTIFUNCTION NANOSYSTEMS
WO2010054321A2 (en) 2008-11-07 2010-05-14 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
WO2011059609A2 (en) 2009-10-13 2011-05-19 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
US8912323B2 (en) 2009-10-30 2014-12-16 The Regents Of The University Of Michigan Multifunctional small molecules
US20110201076A1 (en) 2010-01-22 2011-08-18 Colorado School Of Mines Harvesting micro algae
MX2013013627A (es) 2011-06-21 2014-04-25 Oncofactor Corp Composiciones y metodos para la terapia y diagnostico de cancer.
WO2013085718A1 (en) 2011-12-08 2013-06-13 The Regents Of The University Of Michigan Multifunctional small molecules
US9751936B2 (en) * 2013-03-08 2017-09-05 Regeneron Pharmaceuticals, Inc. Human antibodies to serum resistance-associated protein from trypanosoma brucei rhodesiense

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
WO1981001849A1 (en) * 1979-12-28 1981-07-09 Research Corp Purified human prostate antigen
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4359457A (en) * 1980-09-30 1982-11-16 Neville Jr David M Anti Thy 1.2 monoclonal antibody-ricin hybrid utilized as a tumor suppressant
US4381292A (en) * 1980-11-14 1983-04-26 The Board Of Trustees Of The Leland Stanford Jr. University Anti-human T-lymphocyte monoclonal antibody
US4522918A (en) * 1981-12-15 1985-06-11 Jeffery Schlom Process for producing monoclonal antibodies reactive with human breast cancer
NO830570L (no) * 1982-02-22 1983-08-23 Carlton Med Prod Antistoffer og antigener for diagnose og behandling av cancer
US4507391A (en) * 1982-04-02 1985-03-26 Sloan-Kettering Institute For Cancer Research Method for detecting the presence of GD3 ganglioside
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4569788A (en) * 1983-05-18 1986-02-11 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies against non small cell lung cancer
IL76877A (en) * 1984-11-02 1991-11-21 Oncogen Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies
DK276185D0 (da) * 1984-11-09 1985-06-19 Novo Industri As Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途

Also Published As

Publication number Publication date
WO1986002945A1 (en) 1986-05-22
ES546325A0 (es) 1987-05-16
IL76142A0 (en) 1985-12-31
NO862641D0 (no) 1986-06-30
BR8507031A (pt) 1987-01-06
EP0201509B1 (en) 1989-12-13
ES8705975A1 (es) 1987-05-16
IL76142A (en) 1990-04-29
EP0201509A1 (en) 1986-11-20
CN85107599A (zh) 1986-07-09
AU4725485A (en) 1986-06-03
KR880700061A (ko) 1988-02-15
CN1009055B (zh) 1990-08-08
AU593467B2 (en) 1990-02-08
DK323486D0 (da) 1986-07-07
HUT40692A (en) 1987-01-28
NO862641L (no) 1986-06-30
KR900003923B1 (ko) 1990-06-04
US4708930A (en) 1987-11-24
DE3574730D1 (de) 1990-01-18
CA1243969A (en) 1988-11-01

Similar Documents

Publication Publication Date Title
DK323486D0 (da) Monoklont antistof mod et med human carcinom associeret antigen
DK138786A (da) Monoklont antistof rettet mod humant gangliosid gd2
DK590387D0 (da) Antistoffer mod interleukin-1
DK307986A (da) Klonet antigen
FI88164C (fi) Metalljonskelat med en kelaterande dipyridoxalfosfatfoerening
DK172686D0 (da) Antigen
DK190889A (da) Antigen
KR850009994U (ko) 리크라이너
IT8748196A0 (it) Dispositivo segnatempo differenziale
DK651188A (da) Disulfidholdige pro-laegemidler med antitumorvirkning
ATA261785A (de) Badewanne mit armstuetze
DK324287A (da) Antistof mod koensspecifikt antigen
DK453785D0 (da) Laegemiddel med grf-virkning
KR900700602A (ko) 통상의 급성 임파아구성 백혈병 항원
DK554986D0 (da) Antistof
KR850006361U (ko) 의 자
IT1226635B (it) Sedia
KR890000227U (ko) 간이 의자
FR2619636B1 (fr) Collimateur
SE8404466D0 (sv) Buffered medical preparation
BR6401565U (pt) Assento descartavel
BR6400556U (pt) Encosto descartavel
DK182188D0 (da) Humant tumorassocieret antigen
BR8406304A (pt) Cadeira
IT218864Z2 (it) Sedia

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment